Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Presence of PD-1 similarity genes in monocytes may promote the development of type 1 diabetes mellitus and poor prognosis of pancreatic cancer. | BMJ Open Diabetes Res Care | 2023 | 37130628 | PubTator, text mining | PubMed |
| Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma. | J Immunother Cancer | 2023 | 37130627 | PubTator, text mining | PubMed |
| Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma. | World J Gastrointest Oncol | 2023 | 37123057 | PubTator, text mining | PubMed |
| Computational design of a cyclic peptide that inhibits the CTLA4 immune checkpoint. | RSC Med Chem | 2023 | 37122540 | PubTator, text mining | PubMed |
| Chronic LCMV infection regulates the effector T cell response by inducing the generation of less immunogenic dendritic cells. | Exp Mol Med | 2023 | 37121977 | PubTator, text mining | PubMed |
| A Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer. | Int J Mol Sci | 2023 | 37108377 | PubTator, text mining | PubMed |
| Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy. | Mil Med Res | 2023 | 37106400 | PubTator, text mining | PubMed |
| Novel prognostic features and personalized treatment strategies for mitochondria-related genes in glioma patients. | Front Endocrinol (Lausanne) | 2023 | 37091853 | PubTator, text mining | PubMed |
| Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies. | Front Immunol | 2023 | 37090727 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Immune Infiltration in Non-alcoholic Fatty Liver Disease -Related Hepatocellular Carcinoma by Bioinformatics Analysis. | Turk J Gastroenterol | 2023 | 37089050 | PubTator, text mining | PubMed |
| Development of an endoplasmic reticulum stress-related signature with potential implications in prognosis and immunotherapy in head and neck squamous cell carcinoma. | Diagn Pathol | 2023 | 37087456 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients. | Biosci Rep | 2023 | 37083719 | PubTator, text mining | PubMed |
| Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration. | Int J Gen Med | 2023 | 37077765 | PubTator, text mining | PubMed |
| Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies. | Cell Mol Immunol | 2023 | 37069229 | PubTator, text mining | PubMed |
| Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression. | Transl Oncol | 2023 | 37068401 | PubTator, text mining | PubMed |
| Association of B7H3 and B7H4 gene polymorphisms and protein expression with the development and prognosis of autoimmune thyroid diseases. | Clin Endocrinol (Oxf) | 2023 | 37066992 | PubTator, text mining | PubMed |
| Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective. | Front Oncol | 2023 | 37064113 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma. | Front Oncol | 2023 | 37064086 | PubTator, text mining | PubMed |
| Tim-3 regulates the immunosuppressive function of decidual MDSCs via the Fyn-STAT3-C/EBPβ pathway during Toxoplasma gondii infection. | PLoS Pathog | 2023 | 37058540 | PubTator, text mining | PubMed |
| Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37058053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=22